Could a cough medicine help fight opioid addiction?
NCT ID NCT05976646
First seen May 08, 2026 · Last updated May 08, 2026
Summary
This study tested whether adding a drug called AUVELITY (dextromethorphan and bupropion) to standard buprenorphine/naloxone treatment is safe and helpful for people with opioid use disorder. 18 adults on stable buprenorphine treatment took part. Researchers measured safety (heart rate, blood pressure, side effects) and early signs of benefit like reduced cravings and withdrawal. The goal is to find better ways to manage opioid addiction.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OPIOID-USE DISORDER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CARI Research Clinic- VCU Institute for Drug and Alcohol Studies
Richmond, Virginia, 23219, United States
Conditions
Explore the condition pages connected to this study.